{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+propionate%2Fsalmeterol+combination+product&page=2", "query": { "intervention": "Fluticasone propionate/salmeterol combination product", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 46, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+propionate%2Fsalmeterol+combination+product&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+propionate%2Fsalmeterol+combination+product&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-09T10:37:17.320Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02573233", "title": "Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Dupilumab SAR231893/REGN668", "type": "DRUG" }, { "name": "fluticasone propionate and salmeterol", "type": "DRUG" }, { "name": "budesonide and formoterol", "type": "DRUG" }, { "name": "mometasone furoate and formoterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 42, "start_date": "2016-01-27", "completion_date": "2018-01-03", "has_results": true, "last_update_posted_date": "2022-04-04", "last_synced_at": "2026-10-09T10:37:17.320Z", "location_count": 6, "location_summary": "Tucson, Arizona • Denver, Colorado • Boston, Massachusetts + 3 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02573233" }, { "nct_id": "NCT00118690", "title": "A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bronchospasm", "Activity/Exercise Induced Bronchospasm" ], "interventions": [ { "name": "Fluticasone propionate/salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "4 Years to 17 Years" }, "enrollment_count": 227, "start_date": "2003-12", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2016-09-23", "last_synced_at": "2026-10-09T10:37:17.320Z", "location_count": 51, "location_summary": "Jonesboro, Arkansas • East Artesia, California • Huntington Beach, California + 45 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "East Artesia", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00118690" }, { "nct_id": "NCT00441441", "title": "A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate", "type": "DRUG" }, { "name": "fluticasone propionate/salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 351, "start_date": "2007-02", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-10-09T10:37:17.320Z", "location_count": 20, "location_summary": "Huntington Beach, California • Long Beach, California • Riverside, California + 16 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00441441" }, { "nct_id": "NCT03207243", "title": "Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "GSK3772847", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 165, "start_date": "2017-09-14", "completion_date": "2019-05-15", "has_results": true, "last_update_posted_date": "2020-03-02", "last_synced_at": "2026-10-09T10:37:17.320Z", "location_count": 33, "location_summary": "Birmingham, Alabama • Scottsboro, Alabama • Bakersfield, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsboro", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03207243" }, { "nct_id": "NCT00503009", "title": "Study Of RV-39 In Patients Who Also Have Asthma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "fluticasone propionate", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 16, "start_date": "2007-10", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2016-12-28", "last_synced_at": "2026-10-09T10:37:17.320Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00503009" }, { "nct_id": "NCT01110200", "title": "Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "ADVAIR DISKUS 250/50 mg BID", "type": "DRUG" }, { "name": "SEREVENT 50 mcg BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 639, "start_date": "2010-04-30", "completion_date": "2012-05-08", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-10-09T10:37:17.320Z", "location_count": 74, "location_summary": "Birmingham, Alabama • Florence, Alabama • Mobile, Alabama + 66 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Florence", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01110200" }, { "nct_id": "NCT00355342", "title": "Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Salmeterol 50 mcg BID", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol 250/50 mcg BID", "type": "DRUG" }, { "name": "DISKUS inhaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 186, "start_date": "2004-04-28", "completion_date": "2007-09-06", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-10-09T10:37:17.320Z", "location_count": 37, "location_summary": "Berkeley, California • Fullerton, California • Rancho Mirage, California + 31 more", "locations": [ { "city": "Berkeley", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Rancho Mirage", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00355342" }, { "nct_id": "NCT00118716", "title": "A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bronchospasm", "Activity/Exercise Induced Bronchospasm" ], "interventions": [ { "name": "Fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "Fluticasone Propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "4 Years to 17 Years" }, "enrollment_count": 248, "start_date": "2003-12-23", "completion_date": "2006-04-23", "has_results": true, "last_update_posted_date": "2019-02-05", "last_synced_at": "2026-10-09T10:37:17.320Z", "location_count": 50, "location_summary": "Little Rock, Arkansas • Huntington Beach, California • Orange, California + 45 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palmdale", "state": "California" }, { "city": "Paramount", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00118716" }, { "nct_id": "NCT00857766", "title": "A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "ADVAIR DISKUS™ 250/50mcg", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 249, "start_date": "2009-03", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2017-01-30", "last_synced_at": "2026-10-09T10:37:17.320Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Mobile, Alabama + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00857766" }, { "nct_id": "NCT00346749", "title": "ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Salmeterol", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol Combination Product", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 180, "start_date": "2006-12", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-10-09T10:37:17.320Z", "location_count": 11, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Diego, California + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00346749" } ] }